Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | BCHE | P06276 | 2/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.40 |
| ▸ | JAK2 | O60674 | 3/20 | 0.36 |
| ▸ | JAK1 | P23458 | 3/20 | 0.36 |
| ▸ | TYK2 | P29597 | 3/20 | 0.36 |
| ▸ | JAK3 | P52333 | 2/20 | 0.36 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9769104 | 1.00 | KDM4E (0.46) | KDM4EBCHEADRB2JAK2JAK1 | |
| SCHEMBL9769131 | 0.97 | KDM4E (0.43) | KDM4EBCHEADRB2JAK2JAK1 | |
| SCHEMBL9769140 | 0.97 | KDM4E (0.43) | KDM4EBCHEADRB2JAK2JAK1 | |
| SCHEMBL9769296 | 0.95 | ADRB2 (0.44) | KDM4EBCHEADRB2JAK2JAK1 | |
| SCHEMBL10584351 | 0.95 | ADRB2 (0.44) | KDM4EBCHEADRB2JAK2JAK1 | |
| SCHEMBL9769373 | 0.84 | JAK2 (0.33) | KDM4EBCHEADRB2JAK2JAK1 | |
| SCHEMBL9769377 | 0.84 | JAK2 (0.33) | KDM4EBCHEADRB2JAK2JAK1 | |
| SCHEMBL9769376 | 0.79 | ADRB2 (0.46) | KDM4EADRB2 | |
| SCHEMBL9769372 | 0.79 | ADRB2 (0.46) | KDM4EADRB2 | |
| SCHEMBL9769141 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5019578-A | β-adrenergic agonists | MERCK & CO., INC. (US) | 1991-05-28 | — | — | US | disclosed |
| EP-0318092-A2 | Novel beta-adrenergic agonists | MERCK & CO. INC. (US) | 1989-05-31 | — | — | EP | disclosed |